Iranian Journal of Pediatrics

Published by: Kowsar

Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus

Mohammad Mehdi Bagheri 1 , Pedram Niknafs 1 , Fatemeh Sabsevari 1 , * , Mohammad Hosein Torabi 1 , Bahareh Bahman Bijari 1 , Elahe Noroozi 1 and Hamid Mossavi 1
Authors Information
1 Afzalipour Medical Center, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e3975
  • Published Online: May 15, 2016
  • Article Type: Research Article
  • Received: October 30, 2015
  • Revised: January 28, 2016
  • Accepted: February 5, 2016
  • DOI: 10.5812/ijp.3975

To Cite: Bagheri M M, Niknafs P, Sabsevari F, Torabi M H, Bahman Bijari B, et al. Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus, Iran J Pediatr. 2016 ; 26(4):e3975. doi: 10.5812/ijp.3975.

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Reller MD, Rice MJ, McDonald RW. Review of studies evaluating ductal patency in the premature infant. J Pediatr. 1993; 122(6)-62[DOI]
  • 2. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr. 2006; 148(6): 730-4[DOI][PubMed]
  • 3. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010; 30(4): 241-52[DOI][PubMed]
  • 4. Demirel G, Erdeve O, Dilmen U. Pharmacological Management of PDA: oral versus intravenous medications. Curr Clin Pharmacol. 2012; 7(4): 263-70[PubMed]
  • 5. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2012; 97(4)-83[DOI][PubMed]
  • 6. Zecca E, Romagnoli C, De Carolis MP, Costa S, Marra R, De Luca D. Does Ibuprofen increase neonatal hyperbilirubinemia? Pediatrics. 2009; 124(2): 480-4[DOI][PubMed]
  • 7. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J. 2005; 19(6): 635-7[DOI][PubMed]
  • 8. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011; 128(6)-21
  • 9. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010; 125(5): 1020-30[DOI][PubMed]
  • 10. Pourarian S, Rezaie M, Amoozgar H, Shakiba AM, Edraki MR, Mehdizadegan N. High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates. J Pediatr. 2015; 25(4)
  • 11. Terrin G, Conte F, Scipione A, Bacchio E, Conti MG, Ferro R, et al. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr. 2014; 40(1): 21[DOI][PubMed]
  • 12. Yurttutan S, Oncel MY, Arayici S, Uras N, Altug N, Erdeve O, et al. A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med. 2013; 26(8): 825-7[DOI][PubMed]
  • 13. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014; 164(3): 510-4 e1[DOI][PubMed]
  • 14. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One. 2013; 8(11)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments